 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/15/2024 |
$16.46 |
$16.61 |
$16.05 |
$16.15 |
161.30K | | 04/16/2024 |
$16.03 |
$16.13 |
$15.33 |
$15.36 |
211.00K | | 04/17/2024 |
$15.33 |
$15.40 |
$13.97 |
$14.00 |
190.80K | | 04/18/2024 |
$13.87 |
$13.94 |
$13.22 |
$13.23 |
154.10K | | 04/19/2024 |
$13.10 |
$13.44 |
$12.77 |
$13.32 |
139.40K |
|
|
| Enanta Pharmaceuticals is a biotechnology company that engaged in the discovery and development of small molecule drugs for the treatment of viral infections. Co.'s primary wholly-owned research and development programs are in virology, namely respiratory syncytial virus, severe acute respiratory syndrome coronavirus 2, hepatitis B virus and human metapneumovirus. Co.'s out-licensed products include two protease inhibitors, which are developed through Co.'s Collaborative Development and License Agreement with AbbVie have been clinically tested, manufactured, and commercialized by AbbVie as part of its combination regimens for hepatitis C virus. | |
|
Enanta Pharmaceuticals (ENTA) has the following price history information. Looking back at ENTA historical stock prices for the last five trading days, on April 15, 2024, ENTA opened at $16.46, traded as high as $16.61 and as low as $16.05, and closed at $16.15. Trading volume was a total of 161.30K shares. On April 16, 2024, ENTA opened at $16.03, traded as high as $16.13 and as low as $15.33, and closed at $15.36. Trading volume was a total of 211.00K shares. On April 17, 2024, ENTA opened at $15.33, traded as high as $15.40 and as low as $13.97, and closed at $14.00. Trading volume was a total of 190.80K shares. On April 18, 2024, ENTA opened at $13.87, traded as high as $13.94 and as low as $13.22, and closed at $13.23. Trading volume was a total of 154.10K shares. On April 19, 2024, ENTA opened at $13.10, traded as high as $13.44 and as low as $12.77, and closed at $13.32. Trading volume was a total of 139.40K shares.
ENTA Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Enanta Pharmaceuticals shares, starting with a $10,000 purchase of ENTA, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/22/2014 |
|
| End date: |
04/19/2024 |
|
| Start price/share: |
$36.82 |
|
| End price/share: |
$13.32 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-63.82% |
|
| Average Annual Total Return: |
-9.67% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$3,616.76 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/15/2024 | $16.15 | | 04/16/2024 | $15.36 | | 04/17/2024 | $14.00 | | 04/18/2024 | $13.23 | | 04/19/2024 | $13.32 |
|
|
Free ENTA Email Alerts:
